Nicotine exposure and tardive dyskinesia

Area of Science:

• Neuroscience
• Psychiatry
• Clinical Pharmacology

Background:

• Tardive dyskinesia (TD) is a potential side effect of long-term antipsychotic use.
• The relationship between smoking and TD prevalence is not fully understood.
• Nicotine's effect on dopamine pathways may influence TD development.

Purpose of the Study:

• To investigate the association between smoking and the prevalence of tardive dyskinesia in chronic psychiatric outpatients.
• To explore potential gender-specific differences in this association.
• To examine the role of neuroleptic dosage in the observed relationship.

Main Methods:

• Cross-sectional study design.
• Prevalence assessment of TD in a cohort of chronic psychiatric outpatients.
• Comparison of TD rates between smokers and nonsmokers.
• Analysis of neuroleptic dosage and its correlation with TD in relation to smoking status and gender.

Main Results:

• A significantly higher prevalence of TD was observed in smokers (46/85) compared to nonsmokers (18/69) (p < 0.001).
• Increased neuroleptic dosage was associated with higher TD prevalence in female smokers, but not in male smokers.
• Findings suggest smoking as a potential risk factor for TD development.

Conclusions:

• Smoking is associated with an increased prevalence of tardive dyskinesia in chronic psychiatric outpatients.
• The findings suggest smoking as a modifiable risk factor for TD.
• Further research into nicotine antagonists for TD treatment is warranted.